Ken Griffin Beauty Health CO Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.12 - $2.2 $77,952 - $153,120	-69,600 Reduced 73.81%	24,700 $35,000
Q2 2024 Aug 14, 2024	SELL	$1.77 - $4.28 $175,938 - $425,432	-99,400 Reduced 51.32%	94,300 $181,000
Q1 2024 May 15, 2024	BUY	$2.39 - $4.53 $243,541 - $461,607	101,900 Added 111.0%	193,700 $860,000
Q4 2023 Feb 14, 2024	BUY	$1.39 - $5.86 $65,051 - $274,248	46,800 Added 104.0%	91,800 $285,000
Q3 2023 Nov 14, 2023	SELL	$5.47 - $8.78 $295,927 - $474,997	-54,100 Reduced 54.59%	45,000 $270,000
Q2 2023 Aug 14, 2023	SELL	$7.77 - $13.7 $654,234 - $1.15 Million	-84,200 Reduced 45.94%	99,100 $829,000
Q1 2023 May 15, 2023	BUY	$9.22 - $13.3 $77,448 - $111,720	8,400 Added 4.8%	183,300 $2.32 Million
Q4 2022 Feb 14, 2023	SELL	$8.39 - $13.4 $1.15 Million - $1.83 Million	-136,800 Reduced 43.89%	174,900 $1.59 Million
Q3 2022 Nov 14, 2022	BUY	$10.35 - $15.27 $684,135 - $1.01 Million	66,100 Added 26.91%	311,700 $3.68 Million

129

54.8M

3.71M

394K

Ticker SKIN
Exchange NASDAQ
Sector Consumer Defensive
Industry Household & Personal Products
Shares Outstandng 150,887,008
Market Cap $214M
Description
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Hydra...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.